| Acne |
No |
| Active Half-Life |
2-4 hours |
| Active substance |
Arimistane |
| Also known as |
Arimistane |
| Aromatization |
No |
| Blood pressure |
Can potentially increase if water retention occurs |
| Chemical name |
Androsta-3,5-diene-7,17-dione |
| Classification |
Aromatase Inhibitor |
| Dosage |
50 mg/day |
| Dosage (medical) |
Not typically used for medical purposes |
| Dosage (sports) |
50-75 mg per day |
| Effects |
Increased testosterone levels, decreased estrogen levels |
| Formula |
C19H24O2 |
| Half-life |
48 hours |
| HBR |
No |
| Hepatotoxicity |
No |
| Lab Test |
See Document |
| Main action |
Inhibition of aromatase enzyme, reducing estrogen synthesis |
| Side effects |
Potential hormonal imbalances, risk of joint discomfort, and potential impact on lipid profiles |
| Storage conditions |
Store in a cool, dry place, away from light |
| Substance class |
Steroidal aromatase inhibitor |
| Trade name |
Not commercially available as a medication |
| Use in sports |
Used as an ancillary compound to manage estrogen levels in anabolic steroid cycles |
| WAREHOUSE |
USA Warehouse 2 |
| Water Retention |
No |
| Manufacturer |
Spectre Labs |
